BamSEC and AlphaSense Join Forces
Learn More

Lipella Pharmaceuticals Inc.

NASDAQ: LIPO    
Share price (12/31/24): $3.05    
Market cap (12/31/24): $3.687 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3
from 8-K 15 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 37 pages Subscription for Shares of Series B Non-Voting Convertible Preferred Stock of Lipella Pharmaceuticals Inc
12/34/56
EX-10.3
from 8-K 3 pages Amendment to Consulting Agreement and Placement Agency Agreement
12/34/56
EX-10.2
from 8-K 10 pages Consulting Agreement and Advisory Agreement
12/34/56
EX-10.1
from 8-K 20 pages Placement Agent Agreement
12/34/56
EX-10.2
from 8-K 11 pages Strictly Confidential
12/34/56
EX-10.1
from 8-K 37 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 10-Q 25 pages Lease Agreement Part I - Basic Lease Information
12/34/56
EX-10.2
from 8-K 7 pages Affiliate Stock Purchase Agreement
12/34/56
EX-10.1
from 8-K 7 pages Affiliate Stock Purchase Agreement
12/34/56
EX-10.2
from 8-K 29 pages Registration Rights Agreement
12/34/56
EX-10.1
from 8-K 41 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 1 page Ammendment No. 1 to Employment Agreement
12/34/56
EX-10.1
from 8-K 1 page Ammendment No. 1 to Employment Agreement
12/34/56
EX-10.1
from 8-K 26 pages Lease Agreement Part I - Basic Lease Information
12/34/56
EX-10.19
from S-1/A 5 pages February 9, 2022 Jonathan Kaufman Phd CEO Lipella Pharmaceuticals Inc. 7800 Susquehanna St, Suite 505 Pittsburgh, Pa 15208 Dear Jonathan, This Letter Agreement (This “Agreement”) Will Confirm the Understanding and Agreement Between Young & Partners LLC (“Young & Partners”) and Lipella Pharmaceuticals Inc. (The “Company”) as Follows
12/34/56
EX-10.18
from S-1/A 1 page Promissory Note
12/34/56
EX-10.17
from S-1/A 1 page Promissory Note
12/34/56
EX-10.16
from S-1/A 1 page Promissory Note
12/34/56
EX-10.15
from S-1/A 19 pages Lipella Pharmaceuticals Inc. Form of Indemnification Agreement
12/34/56